1.
Intravitreal bevacizumab (Avastin) injection in ocular ischemic syndrome.
Amselem Luis, Montero Javier, Diaz-Llopis Manuel, Pulido Jose S, Bakri Sophie J, Palomares Paula et al.
Am J OphthalmolJul 200724 citationsCase Series
Intravitreal bevacizumab in two OIS patients reduced iris neovascularization and macular edema, suggesting it may be a useful treatment for these complications.